Medication info
Telmisartan 80 mg (Telmisartan)

Telmisartan 80 mg (Telmisartan)

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›80mg / 1 tablet
Manufacturer / importer
Geonil Biopharm Co., Ltd.
Appearance
White oval tablet
Packaging
30 tablets/PPT [(10 tablets/AluAlu*3)]
Approval status
Active

MFDS item code 202002500 · Approved 2020.04.09 · Insurance code 073000280

Summary

Main use
Treatment of essential hypertension and prevention of cardiovascular diseases (myocardial infarction, stroke, etc.)
Who takes it
Adults
Adult dose
1. Essential hypertension Adults: Telmisartan 40 mg should be administered orally once daily with water, and may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after the start of treatment. This medicine has an additional blood pressure-lowering effect when administered concomitantly with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: It is recommended that this medicine be administered orally at a dose of 80 mg once daily with water, and it may be taken with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When starting treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive agents may be required. ○ Patients with hepatic impairment Administer with caution to patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Ingredients

Manufacturer
Geonil Biopharm Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and prevention of cardiovascular diseases (myocardial infarction, stroke, etc.)

  • Essential hypertension
  • coronary artery disease
  • peripheral artery disease
  • stroke
  • transient ischemic attacks
  • high-risk diabetes with clinical evidence of end-organ damage
  • myocardial infarction
View approved original text

For patients with essential hypertension, this medication helps effectively control blood pressure and maintain cardiovascular health. It is also used to reduce the risk of myocardial infarction, stroke, and death from cardiovascular diseases in high-risk diabetes patients who have a history of coronary artery disease, peripheral artery disease, stroke, transient ischemic attacks, or evidence of end-organ damage and cannot use ACE inhibitors. In summary, this medication is effective in reducing the risk of cardiovascular diseases, including essential hypertension.

How to take

Adult dose

1. Essential hypertension Adults: Telmisartan 40 mg should be administered orally once daily with water, and may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after the start of treatment. This medicine has an additional blood pressure-lowering effect when administered concomitantly with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: It is recommended that this medicine be administered orally at a dose of 80 mg once daily with water, and it may be taken with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When starting treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive agents may be required. ○ Patients with hepatic impairment Administer with caution to patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Precautions

This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters; if pregnancy is confirmed, it should be discontinued immediately. It is not safe for women who are pregnant, potentially pregnant, or breastfeeding to take this medication. Patients with severely impaired liver function or bile secretion issues should avoid taking this medication. Individuals with a history of allergy or hypersensitivity to this medication should not take it. Patients with a history of serious allergic reactions such as angioedema should avoid this medication as well. Patients with diabetes or moderate to severe renal impairment should avoid using this medication in combination with certain other medications and should take it cautiously under medical supervision. Elderly individuals, those with compromised renal function, patients with hyperkalemia, and patients with mildly impaired liver function should exercise special caution when taking this medication. Those who have heart or vascular issues or gastrointestinal diseases should also be careful when using this medication. This medication lowers blood pressure, which can lead to symptoms such as hypotension, dizziness, and fainting, so caution is advised. While taking this medication, serum potassium levels and renal function should be regularly monitored for abnormalities. This medication may interact with other antihypertensives, certain diuretics, lithium, and non-steroidal anti-inflammatory drugs (NSAIDs), so consulting with a physician or pharmacist is necessary when taking it together. Caution is needed when driving or operating dangerous machinery due to the risk of dizziness or fainting. In case of overdose, symptoms such as blood pressure drop, arrhythmia, dizziness, renal impairment, etc., may occur, so immediate contact with a medical institution is necessary. The safety and efficacy of this medication have not been established for children and adolescents under 18 years of age. This medication contains sorbitol, making it unsuitable for patients with certain fructose intolerance.

Side effects

  • Upper respiratory infections
  • pharyngitis
  • sinusitis
  • urinary tract infections
  • cystitis
  • sepsis
  • anemia
  • thrombocytopenia
  • eosinophilia
  • hypersensitivity
Show 116 more
  • anaphylactic reactions
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • depression
  • insomnia
  • anxiety
  • syncope
  • drowsiness
  • visual disturbances
  • dizziness
  • bradycardia
  • tachycardia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • cough
  • interstitial lung disease
  • abdominal pain
  • diarrhea
  • dyspepsia
  • abdominal distension
  • vomiting
  • abdominal discomfort
  • dry mouth
  • taste disturbances
  • liver function abnormalities
  • hepatic impairment
  • increased sweating
  • pruritus
  • rash
  • erythema
  • angioedema
  • drug rash
  • toxic skin rash
  • eczema
  • urticaria
  • myalgia
  • low back pain
  • muscle cramps
  • arthralgia
  • limb pain
  • tendon pain
  • acute renal failure
  • chest pain
  • asthenia
  • influenza-like illness
  • elevated serum creatinine
  • elevated serum uric acid
  • increased liver enzymes
  • elevated serum creatine kinase
  • hemoglobin decrease
  • hypoglycemia
  • malaise
  • hunger
  • cold sweats
  • tremors
  • decreased concentration
  • convulsions
  • altered consciousness
  • facial swelling
  • lip swelling
  • pharyngeal and laryngeal swelling
  • tongue swelling
  • laryngeal edema
  • severe hyperkalemia
  • renal failure
  • shock
  • loss of consciousness
  • liver dysfunction
  • jaundice
  • dyspnea
  • hypotension
  • laryngeal edema
  • fever
  • pneumonia
  • rhabdomyolysis
  • palpitations
  • fatigue
  • nausea
  • lack of efficacy
  • headache
  • dizziness
  • facial spasms
  • sensory disturbances
  • paralysis
  • hyperventilation
  • pneumonia
  • flushing
  • erectile dysfunction
  • decreased appetite
  • arrhythmia
  • asthenia
  • edema
  • decreased libido
  • facial edema
  • rash
  • alopecia
  • conjunctivitis
  • tinnitus
  • petechiae
  • headache
  • dizziness
  • myalgia
  • dermatitis
  • dizziness
  • dyspepsia
  • cough
  • abdominal pain
  • decreased appetite
  • asthenia
  • intestinal vascular edema
  • abdominal pain
  • nausea
  • vomiting
  • diarrhea

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to protect it from air and moisture. The storage temperature should be kept between 1 to 30 degrees Celsius at room temperature.

Appearance and packaging

Appearance

White oval tablet

Package unit

30 tablets/PPT [(10 tablets/AluAlu*3)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.